This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Using Sugar Water to Relieve Pain in Infants

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by The Hospital for Sick Children.
Recruitment status was:  Active, not recruiting
Canadian Institutes of Health Research (CIHR)
Information provided by:
The Hospital for Sick Children Identifier:
First received: September 13, 2005
Last updated: March 11, 2010
Last verified: September 2005

This study will examine the safety and effectiveness of sugar water to relieve pain in newborn infants during painful blood tests and injections. Infants of diabetic mothers who receive repeated blood tests will be compared to infants of healthy mothers who receive routine painful procedures.

We believe that administration of sucrose analgesia for every painful cutaneous procedure performed after delivery will result in less pain during the newborn infant screening test.

Condition Intervention
Pain Infant, Newborn Diabetes Drug: Sucrose

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Effectiveness of Sucrose Analgesia in Reducing Pain Responses in Infants Born to Diabetic and Non-diabetic Mothers: A Randomized Controlled Trial

Resource links provided by NLM:

Further study details as provided by The Hospital for Sick Children:

Primary Outcome Measures:
  • - Infant pain score during the newborn screening test, assessed by the Premature Infant Pain Profile (PIPP), or individual parameters of PIPP (facial grimace, heart rate, oxygen saturation)

Secondary Outcome Measures:
  • (effectiveness):
  • - Effectiveness of sucrose for repeated heel lances
  • - Effectiveness of sucrose in decreasing anticipatory pain responses during venipuncture
  • - Effectiveness of sucrose in decreasing pain response during Vitamin K injection
  • - Determination of relationship between painful procedures and infant response during routine care procedures
  • (safety):
  • - Incidence of vomiting during administration of sucrose
  • - Oxygen saturation during administration of sucrose
  • - Serum Glucose concentrations in infants of diabetic mothers

Estimated Enrollment: 240
Study Start Date: July 2003
Estimated Study Completion Date: July 2005

Ages Eligible for Study:   up to 3 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • healthy newborn infants ≥36 weeks gestation
  • infants born to mothers with diabetes (type 1, type 2, or gestational diabetes that is diet-controlled or insulin-dependent)and infants born to mothers without diabetes

Exclusion Criteria:

  • Admission to the neonatal intensive care unit
  • plan to undergo circumcision during the study period
  • major congenital or neurological anomalies
  • clinical diagnosis of birth asphyxia or seizures
  • receiving analgesics or sedatives
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00213213

Canada, Ontario
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5
Sponsors and Collaborators
The Hospital for Sick Children
Canadian Institutes of Health Research (CIHR)
Principal Investigator: Anna Taddio, PhD The Hospital for Sick Children, Toronto Canada
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Anna Taddio/Principal Investigator, The Hospital for Sick Children Identifier: NCT00213213     History of Changes
Other Study ID Numbers: 1000002771
CIHR MCT-63143
Study First Received: September 13, 2005
Last Updated: March 11, 2010

Keywords provided by The Hospital for Sick Children:
diabetes processed this record on September 21, 2017